文献速递呼吸衰竭与机械通气心脑血管急症

使用罕见检测方法对年龄调整D-二聚体的研究

Investigation of age-adjusted D-dimer using an uncommon assay.
PubMed 文献 · Am J Emerg Med · 2018-09-27
一句话结论在急诊使用D-DU检测时,年龄调整D-二聚体公式可提高特异性并保持高敏感性和阴性预测值。

本研究为回顾性图表审查,纳入2012年1月至2017年7月在三家急诊科就诊的4846例同时接受D-二聚体检测和CT肺动脉造影(CTPE)的成人患者,急性肺栓塞(PE)发生率为8.25%。比较传统阈值230 ng/ml D-DU与两种年龄调整阈值(新公式(年龄×5)-20及ACEP认可的年龄×5(>50岁))的检测特性。传统阈值敏感性99.8%、特异性16.7%、NPV 99.9%;新年龄调整公式敏感性97.0%、特异性27.9%、NPV 99.0%,ACEP公式表现相似。结论认为在适当选择的急诊PE评估患者中,使用D-DU检测的年龄调整D-二聚体可提高特异性并维持高敏感性和NPV。

要点

  • 在4846例急诊患者中,传统D-DU阈值230 ng/ml的敏感性99.8%、特异性16.7%、NPV 99.9%。
  • 新年龄调整公式(年龄×5)-20的敏感性97.0%、特异性27.9%、NPV 99.0%,较传统阈值提高特异性。
  • ACEP认可的年龄调整公式(>50岁用年龄×5)检测特性与新公式相似。
  • 作者认为新公式在检测特性上显示出优于ACEP公式的趋势。
  • 年龄调整D-二聚体适用于适当选择的急诊PE评估患者,使用D-DU检测时。

适用人群与场景

  • 在学术四级医疗系统三家急诊科就诊的成人患者,2012年1月至2017年7月,仅纳入同时接受D-二聚体检测和CTPE成像的患者。

诊断标准与关键阈值

  • 传统未调整阈值:230 ng/ml D-DU。
  • 新年龄调整阈值:(年龄×5)-20。
  • ACEP认可的年龄调整阈值:年龄>50岁时使用年龄×5。

研究设计与关键结果

  • 回顾性图表审查,纳入4846例成人患者,平均年龄52岁,急性PE诊断频率8.25%。
  • 传统D-二聚体阈值230 ng/ml D-DU:敏感性99.8%(95% CI 98.6-100),特异性16.7%(95% CI 15.6-17.8),NPV 99.9%(95% CI 99.3-100)。
  • 新年龄调整阈值(年龄×5)-20:敏感性97.0%(95% CI 94.8-98.4),特异性27.9%(95% CI 26.6-29.2),NPV 99.0%(95% CI 98.3-99.5)。
  • ACEP认可的年龄调整公式(年龄×5,>50岁)表现出与新公式相似的检测特性。

证据类型、等级与局限

  • 证据类型:回顾性图表审查。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在适当选择的急诊PE评估患者中使用D-DU检测时,年龄调整D-二聚体可提高特异性并维持高敏感性和NPV。
  • 作者认为,新公式和ACEP认可的年龄调整公式均表现良好,新公式在检测特性上显示出改善的趋势。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Use of an age-adjusted D-dimer for the evaluation of acute pulmonary embolus (PE) has been prospectively validated in the literature and has become a practice recommendation from major medical societies. Most research on this subject involves the most common D-dimer assays reporting in Fibrinogen Equivalent Units (FEU) with a non-age-adjusted manufacturer-recommended cutoff of 500 ng/ml FEU. Limited research to date has evaluated age-adjustment in assays that report in D-Dimer Units (D-DU), which use a manufacturer-recommended cutoff of 230 ng/ml D-DU. Despite scant evidence, an age-adjusted formula using D-DU has been recently endorsed by the American College of Emergency Physicians (ACEP). This formula seems arbitrary in its derivation and unnecessarily deviates from existing thresholds, thus prompting the creation of our novel-age adjustment formula. The goal of this study was to retrospectively evaluate the test characteristics of our novel age-adjusted D-dimer formula using the D-DU assay in comparison to existing traditional and age-adjusted D-dimer thresholds for the evaluation of acute PE in the ED.

METHODS: This was a retrospective chart review at an academic quaternary health system with three EDs and 195,000 combined annual ED visits. Only patients with D-dimer testing and CT PE protocol (CTPE) imaging were included. Admission and discharge diagnosis codes were used to identify acute PE. Outcome measures were sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV) of an unadjusted traditional threshold (230) compared with both novel and ACEP-endorsed age adjusted thresholds, (Age × 5) - 20 and Age × 5 if >50, respectively. Estimates with their exact 95% threshold were performed.

RESULTS: 4846 adult patients were evaluated from January 2012 to July 2017. Group characteristics include a mean age of 52 and a frequency of acute PE diagnosis by CTPE of 8.25%. Traditional D-dimer cutoff demonstrated a sensitivity of 99.8% (95% CI 98.6-100), specificity of 16.7% (95% CI 15.6-17.8) and NPV of 99.9% (95% CI 99.3-100). Our novel age-adjusted D-dimer thresholds had a sensitivity of 97.0% (95% CI 94.8-98.4), specificity of 27.9% (95% CI 26.6-29.2) and NPV of 99.0% (95% CI 98.3-99.5) with the ACEP-endorsed formula demonstrating similar test characteristics.

CONCLUSION: Use of an age-adjusted D-dimer on appropriately selected patients being evaluated for acute PE in the ED with a D-DU assay increases specificity while maintaining a high sensitivity and NPV. Both our novel formula and the ACEP-endorsed age-adjusted formula performed well, with our novel formula showing a trend towards improved testing characteristics.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Parks C, Bounds R, Davis B, et al. Investigation of age-adjusted D-dimer using an uncommon assay. Am J Emerg Med. 2018. PMID: 30291035. doi:10.1016/j.ajem.2018.09.035

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。